Absence of ERCC1 expression is predictive of complete pathologic response to platinum-based therapy for women with triple negative breast cancer

被引:0
|
作者
Cioffi-Lavina, Maureen [1 ]
Hurley, Jude [2 ]
Jorda, Merce [2 ]
Walker, Gail [2 ]
Gomez-Fernandez, Carmen [2 ]
机构
[1] Jackson Mem Hlth Syst, Miami, FL USA
[2] Univ Miami Hlth Syst, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5502
引用
收藏
页数:1
相关论文
共 50 条
  • [1] ERCC1 Expression and Complete Pathologic Response to Platinum-Based Therapy for Patients with Triple Negative Breast Cancer
    Cioffi-Lavina, M.
    Hurley, J.
    Walker, G.
    Hu, J. J.
    Jorda, M.
    Gomez-Fernandez, C.
    [J]. MODERN PATHOLOGY, 2012, 25 : 30A - 30A
  • [2] ERCC1 Expression and Complete Pathologic Response to Platinum-Based Therapy for Patients with Triple Negative Breast Cancer
    Cioffi-Lavina, M.
    Hurley, J.
    Walker, G.
    Hu, J. J.
    Jorda, M.
    Gomez-Fernandez, C.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 30A - 30A
  • [3] ERCC1 expression in metastatic triple negative breast cancer patients treated with platinum-based chemotherapy
    El Baiomy, M.
    El Kashef, W.
    El Zafarany, M.
    [J]. BREAST, 2017, 32 : S92 - S92
  • [4] ERCC1 expression in triple negative breast cancer
    Ozkan, C.
    Gumuskaya, B.
    Yaman, S.
    Aksoy, S.
    Guler, G.
    Altundag, K.
    [J]. JOURNAL OF BUON, 2012, 17 (02): : 271 - 276
  • [5] Expression of ERCC1 in triple-negative breast cancer
    Ozkan, C.
    Gumuskaya, B.
    Yaman, S.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] ERCC1 and clinical resistance to platinum-based therapy
    Reed, E
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6100 - 6102
  • [7] ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas
    Laufs, Valeria
    Altieri, Barbara
    Sbiera, Silviu
    Kircher, Stefan
    Steinhauer, Sonja
    Beuschlein, Felix
    Quinkler, Marcus
    Willenberg, Holger S.
    Rosenwald, Andreas
    Fassnacht, Martin
    Ronchi, Cristina L.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (02) : 181 - 188
  • [8] Platinum-based systematic therapy in triple-negative breast cancer
    Zhu, Yinxing
    Hu, Yixuan
    Tang, Cuiju
    Guan, Xiaoxiang
    Zhang, Wenwen
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (01):
  • [9] Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy
    Jin, Juan
    Zhang, Wenwen
    Ji, Wenfei
    Yang, Fang
    Guan, Xiaoxiang
    [J]. CANCER BIOLOGY & THERAPY, 2017, 18 (06) : 369 - 378
  • [10] ERCC1 Expression as a Predictor of Resistance to Platinum-based Chemotherapy in Primary Ovarian Cancer
    Muallem, Mustafa Zelal
    Braicu, Ioana
    Nassir, Mani
    Richter, Rolf
    Sehouli, Jalid
    Arsenic, Ruza
    [J]. ANTICANCER RESEARCH, 2014, 34 (1A) : 393 - 399